Barclays CEO diagnosed with non-Hodgkin lymphoma


By Joe Hoppe

Barclays PLC said Monday that Chief Executive Officer C.S. Venkatakrishnan has been diagnosed with non-Hodgkin lymphoma, with treatment expected to last 12 to 16 weeks.

The FTSE 100-listed bank said the cancer has been detected early and the prognosis is good. Mr. Venkatakrishnan will continue to actively manage the company during the treatment period.

Write to Joe Hoppe at

This article was originally published by Read the original article here.

Previous articleMarket Extra: Is the market bottom in? 5 reasons U.S. stocks could continue to suffer heading into next year.
Next articleMarket Snapshot: U.S. stock futures slide as China unrest raises growth fears


Please enter your comment!
Please enter your name here